NVO
$38.26+1.95%
as of close, Oct 7, 2026
☾ AH $38.26 +1.95%
Novo Nordisk A/SStock · Health CareMSCI EAFE 0.7%MSCI World 0.2%MSCI ACWI 0.1%US Stock Market 0.0000%
NVO — Novo Nordisk A/S price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDSDDDDEEDEED
20.040.060.080.0100.0120.0140.00100.0M200.0M$38.26—20162019202120242026
2026-10-07
Price$38.26
MA20$44.70
MA50$47.92
Vol56.2M
Key stats#
Price data
- Price
- $38.26
- YTD price return
- -24.80%
- YTD total return
- -21.05%
- Next earnings
- Nov 4, 2026
- Market cap
- 170B
- Enterprise value
- 184.9B
- Shares outstanding
- 4.4B
- 52W low
- $35.12
- 52W high
- $64.16
- From 52W high
- -40.37%
- From 52W low
- +8.94%
- 52W range
- 11%
- Beta
- 0.74
Volume
- Rel volume
- 1.02×
- 30D volume
- 13.2M
- 30D $ vol
- 543.5M
Fundamentals
- Sales (ttm)
- 46.6B
- Sales/share
- $10.50
- EPS (ttm)
- $3.48
- FCF (ttm)
- 18B
- FCF/share
- $4.05
- Book value/share
- $6.87
- Net margin
- 33.14%
- ROE
- 50.62%
- ROA
- 18.09%
- Debt / equity
- 0.57×
- Current ratio
- 0.80
Growth (CAGR, ttm) · 10Y
- Sales
- +10.85%+23.09%+19.16%n/a
- Net income
- +5.65%+25.36%+19.13%n/a
- Shares
- +0.07%-0.42%-1.11%n/a
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +6.00%+26.25%+20.34%n/a
- Sales/share
- +10.78%+23.60%+20.51%n/a
- Book value/share
- +52.70%+37.05%+25.46%n/a
- Dividend/share
- +6.90%+26.31%+20.47%n/a
- Price
- -35.19%-25.37%-4.90%+6.47%
- Total return
- -31.96%-23.18%-2.75%+8.89%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 11.0×
- P/OI (ttm)
- 8.8×
- Fwd P/E
- 11.2×
- P/S (ttm)
- 3.6×
- P/B (mrq)
- 5.6×
- P/FCF (ttm)
- 9.5×
- EV/EBITDA (fy)
- 8.6×
- EV/Sales (ttm)
- 4.0×
- FCF yield (ttm)
- 10.57%
- Dividend yield (ttm)
- 4.85%
- Buyback yield (realized, 1y)
- -0.07%
- Shareholder yield (realized, 1y)
- 1.98%
- Buyback yield (cash, ttm)
- 0.12%
- Shareholder yield (cash, ttm)
- 4.72%
Vs own 10Y history
- P/E
- 2nd
- P/OI
- 2nd
- P/S
- 2nd
- P/B
- 2nd
Bar = where today’s multiple sits in NVO’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-07#
1D
+1.95%
5D
+0.92%
1M
-17.90%
3M
-22.93%
YTD
-24.80%
1Y
-35.17%
5Y
-22.22%
Recent filings#
No earnings release, press release or insider trade outside a 10b5-1 plan in the last 120 days.
All filings and insider trades →Financial statements
Open full NVO financials →Loading financial statements…
Related Health Care#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| NVS | Novartis AG | -10.44% | +1.77% |
| SNY | Sanofi ADS | -9.13% | +1.62% |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | -5.75% | +0.90% |
| TAK | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | -0.43% | +1.49% |
| ARGX | argenx SE American Depositary Shares | -10.14% | -0.22% |
| NTRA | Natera Inc. | +20.53% | -1.27% |
| TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | +7.76% | +0.13% |
| RVMD | Revolution Medicines Inc. | -4.36% | +0.50% |
